Use of Colchicine and Steroids in the Treatment of Alcoholic Liver Disease
To date, only one group has reported its clinical experience with colchicine therapy. This study included a randomized clinical trial of 22 patients and an open study of 53 patients. The beneficial effect of 1 mg colchicine daily for five days a week has been promising but not convincing.
Corticosteroid therapy for the treatment of alcoholic hepatitis was evaluated in nine short-term randomized clinical trials that included 150 treated and 161 control patients with a mortality rate of 37 and 44%, respectively. In these studies, encephalopathy was present in 80 treated and 76 control patients with a mortality rate of 59 and 74%, respectively. None of these differences is significant. The studies did document that patients with mild disease require no specific therapy besides abstinence and general supportive measures; those with severe disease showed a trend toward better survival on corticosteroid therapy. This trend was strong in the earlier publications, but was absent in the most recent studies, which included the largest numbers of patients.
KeywordsCorticosteroid Therapy Alcoholic Liver Disease Chronic Active Hepatitis Alcoholic Hepatitis Prednisolone Therapy
Unable to display preview. Download preview PDF.
- 3.Leevy CM, Kanagasundaram N, Matsumoto K, et al: Alcoholic hyalin and immunologic reactivity, in Eddleston ALWF, Weber JCP, Williams R (eds): Immune Reactions in Liver Disease. Kent, England, Pitman Medical, 1979, pp 195–207.Google Scholar
- 5.MacSween RNM: Immune responses to hyalin, in Eddieston ALWF, Weber JCP, Williams R (eds): Immune Reactions in Liver Disease. Kent, England, Pitman Medical, 1979, pp 215–217.Google Scholar
- 6.Swerdlow M, Chowdhury L, Horn T: Morphologically distinctive markers of alcoholic liver disease. Lab Invest 44:64A–65A, 1981.Google Scholar
- 8.Popper H: Summary of the conference, in Gerlach U, Pott G, Rauterberg J, Voss B (eds): Connective Tissue of the Normal and Fibrotic Human Liver: Present State of Biochemistry, Clinical Evaluation and Treatment. Stuttgart, Georg Thieme Verlag, 1982, pp 246–258.Google Scholar
- 11.Galambos JT: Cirrhosis. Philadelphia, WB Saunders, 1979.Google Scholar
- 12.Galambos JT: Clues from clinical patterns of disease, in Eddleston ALWF, Weber JCP, Williams R (eds): Immune Reactions in Liver Disease. Kent, England, Pitman Medical, 1979, p 224.Google Scholar
- 13.Eddleston ALWF: Alcoholic liver disease: Immunology and treatment, in Proceedings of the 12th International Congress of Chemotherapy. American Society for Microbiology (in press).Google Scholar
- 24.Ehrlich HP, Bornstein P: Microtubules in transcellular movement of procollagen. Nature (London) New Biol 238:257–260, 1972.Google Scholar
- 31.Nicholson GK, Poste G, Ji TH: in Poste G, Nicolson GL (eds): Dynamic Aspects of Cell Surface. Amsterdam, North-Holland, 1977, pp 1–73.Google Scholar
- 33.Garcia-Tsao G, Mourelle M, Rojkind M: Colchicine improves alkaline phosphatase activity in plasma membranes of CCl4 treated rats. Gastroenterology 79:1018, 1980 (abstract).Google Scholar